Is the Antiglobulin Test a Good Marker for Predicting the Development of Hemolytic Disease of the Newborn in ABO Incompatibility?
We read with great interest the article by Valsami et al1 that reported the importance of the direct antiglobulin test (DAT) in cord blood for predicting the development of hemolytic disease of the newborn (HDN). They concluded that, although ABO incompatibility remains the main cause of a positive DAT, other causes, such as alloimmunization and drug interactions should also be investigated. In addition, they suggested that the relevant impact of DAT positivity on the development of HDN should be considered.
Source: Pediatrics and Neonatology - Category: Perinatology & Neonatology Authors: Mustafa Aydin, Ugur Deveci, Aysen Orman, Erdal Taskin Tags: Letter to the Editor Source Type: research
More News: Pediatrics | Perinatology & Neonatology